Biosurveillance : A Review and Update

Abstract EN

Since the terrorist attacks and anthrax release in 2001, almost $32 billion has been allocated to biodefense and biosurveillance in the USA alone.

Surveillance in health care refers to the continual systematic collection, analysis, interpretation, and dissemination of data.

When attempting to detect agents of bioterrorism, surveillance can occur in several ways.

Syndromic surveillance occurs by monitoring clinical manifestations of certain illnesses.

Laboratory surveillance occurs by looking for certain markers or laboratory data, and environmental surveillance is the process by which the ambient air or environment is continually sampled for the presence of biological agents.

This paper focuses on the ways by which we detect bioterrorism agents and the effectiveness of these systems.